Scientists at The Scripps Research Institute (TSRI) have announced the development of the first stable semisynthetic organism. Building on their 2014 study in which they synthesized a DNA base pair, the researchers created a new bacterium that uses the four natural bases (called A, T, C and G), which every living organism possesses, but that also holds as a pair two synthetic bases called X and Y in its genetic code.
TSRI Professor Floyd Romesberg and his colleagues have now shown that their single-celled organism can hold on indefinitely to the synthetic base pair as it divides. Their research was published January 23, 2017, online ahead of print in the journal Proceedings of the National Academy of Sciences. Rest
Now, for the first time, scientists from Harvard Medical School have managed to “listen in” on the crosstalk between individual microbes and the entire cast of immune cells and genes expressed in the gut.
The experiments, published Feb. 16 in Cell, provide a blueprint for identifying important microbial influencers of disease and health and can help scientists develop precision-targeted treatments.
Past research has looked at links between disease and the presence or absence of certain classes of bacteria in the gut. By contrast, the HMS team homed in on one microbe at a time and its effects on nearly all immune cells and intestinal genes, an approach that offers a more precise understanding of the interplay between individual gut microbes and their hosts. Beyond that, the team said, the approach could help scientists screen for molecules or bacterial strains that can be used therapeutically to fine-tune certain immune responses.
“We set out to map out interactions between bacteria and the immune system in the hope that this could eventually lead to the development of an apothecary of agents tailored to modulate the immune system selectively and precisely,” said senior investigator Dennis Kasper, professor of medicine and microbiology and immunobiology at HMS. Rest
Abstract: Natural Killer (NK) cells are essential for control of viral infection and cancer. NK cells express NKG2D, an activating receptor that directly recognizes NKG2D ligands. These are expressed at low level on healthy cells, but are induced by stresses like infection and transformation. The physiological events that drive NKG2D ligand expression during infection are still poorly understood. We observed that the mouse cytomegalovirus encoded protein m18 is necessary and sufficient to drive expression of the RAE-1 family of NKG2D ligands. We demonstrate that RAE-1 is transcriptionally repressed by histone deacetylase inhibitor 3 (HDAC3) in healthy cells, and m18 relieves this repression by directly interacting with Casein Kinase II and preventing it from activating HDAC3. Accordingly, we found that HDAC inhibiting proteins from human herpesviruses induce human NKG2D ligand ULBP-1. Thus our findings indicate that virally mediated HDAC inhibition can act as a signal for the host to activate NK-cell recognition. DOI: 10.7554/eLife.14749.001
In a microscopic feat that resembled a high-wire circus act, Johns Hopkins researchers have coaxed DNA nanotubes to assemble themselves into bridge-like structures arched between two molecular landmarks on the surface of a lab dish. This self-assembling bridge process, which may someday be used to connect electronic medical devices to living cells, was reported by the team recently in the journal Nature Nanotechnology. Rest
The University of Groningen (a university I had the pleasure of visiting several years ago) news article. An excerpt below:
“Feringa is internationally recognized as a pioneer in the field of molecular engines, as the many citations in a background article on nano engines in Nature confirm. One of the potential applications of his engines is the delivery of medication inside the human body. Besides molecular engines, Feringa is also involved in catalysis and smart medication that can, for instance, be turned on and off by light.”
Nature has inspired generations of people, offering a plethora of different materials for innovations. One such material is the molecule of the heritage, or DNA, thanks to its unique self-assembling properties. Researchers at the Nanoscience Center (NSC) of the University of Jyväskylä and BioMediTech (BMT) of the University of Tampere have now demonstrated a method to fabricate electronic devices by using DNA. The DNA itself has no part in the electrical function, but acts as a scaffold for forming a linear, pearl-necklace-like nanostructure consisting of three gold nanoparticles. …
Gold nanoparticles are attached directly within the aqueous solution onto a DNA structure designed and previously tested by the involved groups. The whole process is based on DNA self-assembly, and yields countless of structures within a single patch. Ready structures are further trapped for measurements by electric fields. Rest
Rather than redesigning naturally occurring sequences, researchers employing protein de novo design use peptides that assemble and fold into protein-like structures, relying on two self-assembly principles: The first is peptide-based  and incorporates a coiled coil where the resulting folding profile is much easier to predict, helping scientists overcome a common headache in protein design.
The second principle utilizes oligonucleotides (ON),which are widely used in nanotechnology to generate higher-level structures , for example in DNA origami. What would happen if researchers combined both principles in the same design? In a new proof-of-concept paper recently published in Nature Communications, Wengel’s team answered this question while designing a novel class of artificial proteins . Rest
Microscopic creatures called tardigrades are among the most resilient animals on Earth, able to survive against extreme temperatures, dehydration and even the harsh conditions of space.
A paper published Tuesday in the journal Nature Communications offers new clues to tardigrades’ toughness and addresses a continuing debate over how these unusual animals evolved. Rest (WSJ paywall)
The genome editing project of the OECD Working Party on Biotechnology, Nanotechnology and Converging Technologies (BNCT) aims to produce a forum conducive to evidence-based discussion aross countries on the many issues of shared concern. The initiative aims to help guide policy at the national and international levels and promote — where appropriate — cooperative governance approaches. Rest